X. Cahu

发表

Uncoupling JAK2 V617F activation from cytokine-induced signalling by modulation of JH2 αC helix

A. Shiau, A. Dusa, Amir Motamedi, 2016, The Biochemical journal.

Impact of body‐surface area on patients’ outcome in younger adults with acute myeloid leukemia

M. Bernard, P. Chevallier, M. Béné, 2017, European journal of haematology.

Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution

P. Chevallier, M. Mohty, P. Moreau, 2016, Bone Marrow Transplantation.

Follicular lymphoma prognostic factors in the modern era: what is clinically meaningful?

P. Solal-Céligny, G. Cartron, X. Cahu, 2010, International journal of hematology.

Peripheral Blood Plasmacytoid Dendritic Cells at Day 100 Can Predict Outcome after Allogeneic Stem Cell Transplantation.

P. Chevallier, M. Mohty, M. Grégoire, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation

P. Chevallier, M. Mohty, P. Moreau, 2012, Bone Marrow Transplantation.

18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group.

R. Houot, P. Moreau, A. Moreau, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)

M. Robin, P. Chevallier, I. Yakoub-Agha, 2014, Bone Marrow Transplantation.

Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation

P. Chevallier, M. Mohty, P. Moreau, 2011, Leukemia.

18F-FDG PET/CT for the assessment of gastrointestinal GVHD: results of a pilot study

P. Chevallier, M. Mohty, P. Moreau, 2014, Bone Marrow Transplantation.

Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation

P. Chevallier, M. Mohty, M. Béné, 2015, Annals of Hematology.

Lymphomes malins non hodgkiniens Non-hodgkin ’ s lymphomas

M. Mahé, X. Cahu, Y. Pointreau, 2010 .

Allogeneic hematopoietic stem cell transplantation following reduced‐intensity conditioning regimen in children: a single‐center experience

M. Mohty, N. Corradini, X. Cahu, 2012, European journal of haematology.

Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignancies.

P. Chevallier, M. Mohty, P. Moreau, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia.

A. Baruchel, M. Arcangeli, B. Colsch, 2017, Blood advances.

Oncogenic Drivers in Myeloproliferative Neoplasms: From JAK2 to Calreticulin Mutations

S. Constantinescu, X. Cahu, 2015, Current Hematologic Malignancy Reports.

Rapid childhood T-ALL growth in xenograft models correlates with mature phenotype and NF-κB pathway activation but not with poor prognosis

A. Baruchel, V. Baud, F. Pflumio, 2014, Leukemia.

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT

J. Esteve, M. Labopin, J. Finke, 2016, Bone Marrow Transplantation.

Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression

A. Baruchel, J. Gross, C. Deswarte, 2014, EMBO molecular medicine.

Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies.

P. Chevallier, M. Mohty, P. Moreau, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens

D. Blaise, M. Mohty, P. Moreau, 2008, Bone Marrow Transplantation.

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

F. Jardin, T. Petrella, E. Macintyre, 2019, Blood advances.

Impact of High Body Surface Area on AML Outcome in Younger Patients: A Goelams Study

M. Béné, C. Récher, J. Hamel, 2014 .

Cutaneous macroglobulinosis treated with bortezomib and rituximab

R. Houot, T. Lamy, P. Tas, 2011, European journal of haematology.

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with T-Cell Acute Lymphoblastic Leukemia: A Survey From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

J. Esteve, M. Labopin, I. Yakoub-Agha, 2012 .

F-fluorodeoxyglucose–positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group

C. Bodet-Milin, T. Gastinne, S. Gouill, 2011 .

Cutaneous macroglobulinosis treated with bortezomib and rituximab

R. Houot, T. Lamy, X. Cahu, 2011, European journal of haematology.